Optimal Time for In-situ Dry Needling to Affect the Autonomic Nervous System
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03728751|
Recruitment Status : Completed
First Posted : November 2, 2018
Last Update Posted : November 2, 2018
|Condition or disease||Intervention/treatment||Phase|
|Healthy||Procedure: Dry needling||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||Single group pre-test post test study design|
|Masking:||None (Open Label)|
|Official Title:||Optimal Time for In-situ Dry Needling to Affect the Autonomic Nervous System: A Pilot Study|
|Actual Study Start Date :||September 1, 2018|
|Actual Primary Completion Date :||October 15, 2018|
|Actual Study Completion Date :||October 29, 2018|
Experimental: study group
Study group receiving dry needling and pupil diameter will be studied up to 23 minutes after needle placement.
Procedure: Dry needling
Paravertebral dry needling C7-T4. Total of 8 needles.
- Pupil diameter [ Time Frame: 1.) 1 minute measure will be taken after accommodation of 2 minutes to the dark environment, 2.) needle placement and an immediate 1 minute second measure, 3.) every 2 minutes a measure of 1 minute to 8 post needle measures (24 minutes) total ]Change in pupil diameter measured with automated pupillometry device from Micromedical.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03728751
|United States, Indiana|
|Integrated Therapy Practice PC|
|Hobart, Indiana, United States, 46342|
|Principal Investigator:||Rob Sillevis, PhD||Faculty|